ImmunoGen, Inc. provided earnings guidance for the year 2022. For the year, the company now expects revenues between $80 million and $90 million.
1st Jan change | Capi. | |
---|---|---|
+34.60% | 52.85B | |
-7.23% | 38.87B | |
+34.86% | 38.24B | |
-11.12% | 26.79B | |
+12.05% | 26.16B | |
-20.04% | 19.9B | |
+39.19% | 13.18B | |
+30.10% | 12.24B | |
-3.32% | 11.79B |